It is a business services foreign private limited company based in Mumbai, Maharashtra, India, established in 2018.
2018 | Mumbai, Maharashtra, India | ActiveTacoma Pharmasolutions Private Limited, a active foreign private limited company, was established on 24 July 2018 in Mumbai, Maharashtra, India. Engaging in business support services within the business services sector, it holds CIN: U33309MH2018FTC312162. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹10.00 K and a paid-up capital of ₹10.00 K .
Its leadership includes Gopalakrishna Subray Bhat (Director), Duane Joel Hadfield (Director), Joseph William Hoff (Director). Past directors included Gopalakrishna Subray Bhat, Duane Joel Hadfield, Lauren Elizabeth Hoff. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at E-702,Pruthvi Enclave Co-Op Hsl,Village Magthane,W.E.Highway,Borivali East,, Mumbai, Maharashtra, 400066.
U33309MH2018FTC312162
312162
24 July 2018
₹10.00 K
₹10.00 K
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Tacoma Pharmasolutions Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Gopalakrishna Subray Bhat | Director | 26 Mar 2021 | Current |
| Duane Joel Hadfield | Director | 27 Oct 2020 | Current |
| Joseph William Hoff | Director | 24 Jul 2018 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 08 Nov 2021 | Past |
| Pramod Abcsdd | Additional Director | 31 Dec 2020 | Past |
| Pramod Abcsdd | Additional Director | 08 Nov 2021 | Past |
| Pramod Abcsdd | Director | 10 May 2021 | Past |
| Pramod Abcsdd | Director | 27 Oct 2020 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Tacoma Pharmasolutions Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 57057.59% increase. The company also saw a substantial improvement in profitability, with a 110.97% increase in profit. The company's net worth Soared by an impressive increase of 10.99%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Tacoma Pharmasolutions's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Tacoma Pharmasolutions, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Tacoma Pharmasolutions, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Tacoma Pharmasolutions's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Tacoma Pharmasolutions Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Tacoma Pharmasolutions Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was recorded as a recent event.
Gopalakrishna Subray Bhat was appointed as a Director was appointed as a Director on 26 Mar 2021 & has been associated with this company since 4 years 8 months . was recorded as a recent event.
The activity Duane Joel Hadfield was appointed as a Director was appointed as a Director on 27 Oct 2020 & has been associated with this company since 5 years 1 month . was completed.
Joseph William Hoff was appointed as a Director was appointed as a Director on 24 Jul 2018 & has been associated with this company since 7 years 4 months . was recorded as a recent event.
Progress on Tacoma Pharmasolutions Private Limited was registered on 24 Jul 2018 with Roc Mumbai & aged 7 years 4 months as per MCA records. was documented.
The CIN of Tacoma Pharmasolutions Private Limited is U33309MH2018FTC312162.
Tacoma Pharmasolutions Private Limited is headquartered at E-702,Pruthvi Enclave Co-Op Hsl,Village Magthane,W.E.Highway,Borivali East,, Mumbai, Maharashtra, 400066.
Tacoma Pharmasolutions Private Limited was incorporated on 24 July 2018.
The current directors of Tacoma Pharmasolutions Private Limited are
The primary industry of Tacoma Pharmasolutions Private Limited is Business Services.
Tacoma Pharmasolutions Private Limited is unlisted.
The authorized capital of Tacoma Pharmasolutions Private Limited is ₹10.00 K , and the paid-up capital is ₹10.00 K .
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX